Introduction
Since the emergence of 3'-azido-3'-deoxythymidine (AZT,zidovudine) as the first drug for the treatment of AIDS (Mitsuya et al., 1985; Furman et aI., 1986) , many other nucleoside analogues have been found to possess antiviral activity against HIV-1 (Nasr et aI., 1990; Mitsuya et al., 1991; Schinazi et aI., 1992a) . Replacement of the 3'hydroxyl group of the 2'-deoxyribose ring by an azido, fluoro, or certain other groups, and conversion to the corresponding nucleotide, results in inhibition of the viral enzyme reverse transcriptase. Other modifications at the 3'-position have also produced very active compounds. These include 2',3'-didehydro-3'-deoxythymidine (Lin et al., 1987) , dioxolane analogues of thymidine and cytidine (Norbeck et al., 1989; Kim et aI., 1992) and 3'-thia-2' ,3'dideoxycytidine (BCH-189) (Soudeyns et aI., 1991; Beach et aI., 1992; Schinazi et al., 1992b) .
Racemic cis-5-fluoro-1-[2-(hydroxymethyl)-1,3oxathiolan-5-yl]cytosine (FTC), the 5-fluoro analogue of BCH-189, was found to be a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) in human lymphocytes and in the human hepatoblastoma-derived cell line 2.2.15, respectively (Doong et aI., 1991; Schlnazl et al., 1992c) . The unusual (-)-enantiomer of FTC was more potent than the (+)-isomer against these two viruses (Chang et aI., 1992; Furman et aI., 1992; Schinazi et aI., 1992c) . As for (-)-BCH-189 and (+)-BCH-189 (Sommadossi et aI., 1992) , (-)-FTC has been shown to possess lower toxicity than (+)-FTC and to be more stable to cytidine deaminases (Furman et aI., 1992) . Both enantiomers require phosphorylation to their respective triphosphate nucleotide for activity (Schinazi et al., 1992c) . The initial phosphorylation step is mediated by 2'-deoxycytidine kinase (Shewach et al., 1993) . This suggests a chain termination mechanism of action similar to that of other modified dideoxyribose nucleoside and unlike that of acyclic nucleosides such as 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPl) (Baba et al., 1991) . Because (-)-FTC is currently undergoing advanced preclinical studies, it was important to determine its absolute configuration and to compare its crystal structure to those of related compounds such as the antiviral agent 2',3'dideoxycytidine (DDC) (Birnbaum et aI., 1988) and the N 4 -(4-bromobenzoyl) derivative of (-)-BCH-189 (Storer et aI., 1993). Crystallographic studies ofthe conformations of the compounds could provide insight into their biological similarities and differences. Comparison with DOC is of particular interest because of the lack of cross resistance to DOC of HIVvariants resistant to (-)~FTC (Schinazi et aI., 1993) . Figure 1a shows a schematic diagram of the (-)-FTC enantiomorph with the numbering scheme used in the text and tables. The numbering scheme used for the oxathiolane ring differs from the standard nucleoside numbering scheme, shown in Fig. 1b , but is consistent with the IUPAC recommendations for oxathiolane compounds. Determination of the absolute configuration, while not routine for most nucleoside analogues, is possible for this compound because of the presence of the sulphur atom which has a significant anomalous scattering effect. The y-coordinate of S3'A was held fixed to define the origin.
The atomic coordinates for (-)-FTC are listed in Table 1 . Figure 2 shows the two independent molecules in the asymmetric unit. Table 2 lists the most important geometric and conformational parameters. The full geometry of the oxathiolane ring is listed in the Table because this ring is very uncommon and its geometry is unusual. Twentythree examples can be found in the Cambridge Crystallographic Database (Allen et al., 1979) , but the majority are compounds, such as steroid analogues, in which the ring is highly constrained. The insertion of the large sulphur atom in the five-membered ring puts significant strain on
Results
(-)-FTC crystallizes in the monoclinic space group P2 1.ln order to determine the absolute configuration, a full hemisphere of intensity data with h 2:: 0 was measured and the Bijvoet pairs h,k,l and h,-k,/were not averaged during data reduction. Both enantiomorphs were then refined against this data set. At the end of the refinement of the non-hydrogen atoms with anisotropic thermal parameters, but prior to refinement of the hydrogen atoms, the crystallographic residuals and the standard deviation of an observation of unit weight for both enantiomorphs were: (-)-FTC: R = 0.068, R = 0.081, s = 2.006, and, (+)-FTC: R = 0.075, R = 0.090, s = 2.220. The lower R-values for the (-)-FTC enantiomorph indicate that this is the correct enantiomorph. The difference of 0.07 in the R-values is significant and about as large as one would expect for the contribution of the anomalous scattering of one sulphur atom per 16 non-hydrogen atoms. Further refinement, including the hydrogen atoms was continued only for the correct enantiomer. (The atomic coordinates, anisotropic thermal parameters have been deposited with the Cambridge Crystallographic Database.) the ring. In both molecules the ring adopts a nearly perfect envelope conformation with the sulphur out of the plane of the other atoms. R.m.s. and maximum deviations from planarity for the four atoms 01', 02', 04' and 05' are 0.075 and 0.095 A for molecule Aand 0.056 and 0.071 A for molecule B. The sulphur atoms are 0.71 and 0.74A out of these planes. Both sulphur atoms are below the plane of the ring, in a S3'-exo conformation. The angles at 02', S3' and 04' are all more acute than would be observed in a less strained environment: 105°for the angles at the carbon atoms and less than 90°at the sulphur atoms.
Two crystallographic studies related oxathiolane compounds have recently been reported. Storer et al. (1993) reported the structure and absolute configuration of (2' R,5' S)-N 4-(4-bromobenzoyl)-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosirie, the 4-bromobenzoyl deriva- C5' N1 1.453 (7) 1.489 (7) C5' 01' 1.432 (7) 1.415(6) C2' 01' 1.419 (6) 1.431 (7) (Johnson, 1976) stereodiagram showing the molecular conformations of the two molecules in the asymmetric unit. The molecules shown illustrate the intermolecular base pairing hydrogen bonding. Thermal ellipsoids are shown at 50% probability.
tive of (-)BOH-189. Humber et al. (1992) published a figure of the structure of an oxathiolane acid, an intermediate in the preparation of enantiomerically pure (-)-BOH-189. Both figures suggest an S3'-endo conformation for the oxathiolane ring. However, neither paper includes sufficient detail about the crystallographic study or conformational analysis to allow a full evaluation. A description of the molecular conformation in terms similar to those used for the standard nucleoside conformational parameters is somewhat complicated because of the change in enantiomorph. Therefore, conformations are described explicitly with reference to the corresponding nucleoside conformations. For reviews on nucleoside conformations, see Saenger (1984) and Birnbaum and Shugar (1987) . The glycosylic link in molecule A is in a conformation that places 06 of the base above the centre of the oxathiolane ring. In molecule B, 06 is eclipsed with 01'. The former conformation is similar to the anti (x --130°) glycosylic bond conformation commonly observed in standard nucleosides. The second one, corresponding to high-anti (x --90°), is not observed in saturated pyrimidine nucleosides but is quite common for purine and 2' ,3'-unsaturated pyrimidine nucleosides (Gurskaya et al., 1991; Van Roey et al., 1993) . The orientation of the 07' -hydroxyl group adopts two typical conformations, above the ring in molecule A, corresponding to +sc, and outside the ring, trans to S3' in molecule B, corresponding to ap. The oxathiolane ring conformations are nearly pure S3'-exo envelope conformations with only slight but different twist contributions, S3'-exo/04'-endo for molecule A and S3'-exo/ 02'-endo for molecule B. The crystal packing, shown in Fig. 3 , has some very distinct features. There are no close contacts between the molecules related by the two-fold screw axis. There are two independent bands, two molecules wide, running through the crystal perpendicular to the b-axis. The cores of these bands are composed of closely packed bases, surrounded above and below by the oxathiolane groups. The interfaces between the bands are very hydrophobic, consisting solely of the sulphur atoms and the C2' and C6'-methylene groups. Within these bands two independent molecules, A and B, form head-to-tail hydrogen bonded pairs, each using an N4 amine hydrogen donor and an 07' hydroxyl acceptor. The remaining hydrogen donors, the second amine and the 07' hydroxyl, and acceptor, N3, form three hydrogen bonds with the other molecule of a neighbouring pair, so that a wavy, continuous sheet of hydrogen bonded molecules is formed through the crystal, along the direction ofthe c-axis, Table  3 lists all the intermolecular hydrogen bonds in the structure. These sheets are packed and stabilized by base stacking in which N4 is place above the centre of a base in the one direction and F6 above N3 in the other direction and contacts involving close proximity of F7 and H6 of two unrelated molecules.
Discussion
There has been an increased interest in developing enantiomerically pure drugs in the last 5 years (Amato, 1992 , Stinson, 1992 . The expectations are that one enantiomer may have a therapeutic advantage over the other. Most recently, Milton et a/. (1992) demonstrated the importance of enantiomers by synthesizing the unnatural D-HIV-1 protease and showed the reciprocal chiral substrate specificity of this enzyme using chiral proteinase inhibitors. Among the nucleosides evaluated to date, few have been shown to have the in vitro potency, selectivity and pharmacological profile of (-)-FTC (Furman et aI., 1992; Schinazi et a/., 1992c Schinazi et a/., , 1992d . Of significance was the finding that (-)-FTC has potent and selective activity against HIV-1, HIV-2, simian immunodeficiency virus, feline immunodeficiency virus, and, most importantly, HBV in culture. The latter activity is thought to result from the inhibition of an HBV reverse transcriptase by the 5'-triphosphate of (-)-FTC (Furman et aI., 1992) . The compound has low toxicity to various mammalian cells including human bone marrow cells. (-)-FTC and (-)-BCH-189 are the only two compounds that demonstrate greater antiviral activity in vitro than their mirror images, the corresponding (+)-enantiomers (Schinazi et aI., 1992a (Schinazi et aI., , 1992b (Schinazi et aI., , 1992c . Therefore, it was very important to confirm the assignment of the correct enantiomorph of the more active enantiomer of FTC to 5-fluoro-(2'R,5'S)-(-)-1-[2-(hydroxymethyl)oxathiolan-5-yl]-cytosine. The discovery that the (-)-enantiomer of a nucleoside analogue can have greater activity than the natural (+)-enantiomer should have major implications for drug design and development.
The observed conformations of (-)-FTC have some highly unusual features when compared with the conformations of standard nucleoside analogues that have been studied for their antiviral activity. The high antiglycosylic link conformation observed in molecule B is unusual for pyrimidine nucleosides. It is observed only when the steric hindrance between the base and the sugar ring is reduced by the absence of a 2'-'up' hydrogen atom as in 2 f ,3'-didehydro-2' ,3f -dideoxypyrimidine nucleosides (Van Roey et a/., 1993) and compounds that have a (5) x-1, y, z-1 exo-oriented three-membered ring fused to the 2'-and 3'-carbon atoms (Koole et aI., 1991) . In (-)-FTC, the 2' -carbon is replaced by the 01' -oxygen, which not only reduces the steric effect but has an energetically favourable interaction with H6 of the base.The oxathiolane ring is observed in two S3' -exo conformations, as probably should be expected since the bulk of the sulphur atom would cause major steric interactions if it were in an endo-conformation. However, it should be noted that these conformations, especially the one of molecule B, are unusual but similar to the C3'-exo/C4'-endo (pseudorotational angle P> 180°)conformation frequently observed for active 2',3'-dideoxynucleosides, such as DOC (Birnbaum et aI., 1988), AZT and its uracil analogue (Van Roey et al., 1988 )and 2',3'-dideoxyadenosine (DDA) (Chu et aI., 1989) . The change in enantiomorph does not affect the main effect of this extreme conformation: making both the base and the hydroxymethyl group axial and restricting the conformational freedom of the 7' -hydroxyl group.
We have made numerous attempts to compare the conformations of (-)-FTC with tho §~of other antiviral 2' ,3'-dideoxyribose nucleosides int~ltorts to determine whether some common relationship between the location of the base and that of the hydroxyl group could be found, similar to our analyses of 2' ,3'-dideoxy-, 3'-substituted-2' ,3' -dideoxy-and 2' ,3' -didehydro-2',3' -dideoxynucleosides . This has been done primarily by least-squares fitting various components of the molecules, such as the base or the four central atoms (N1, C5', 01', C4') and evaluating the relative locations of the different moieties of interest. No satisfactory fit, in which C6', 07' and C4 would coincide with the corresponding atoms of standard nucleosides (C5', 05' and C4) has been found. Superpositions with examples of all typical nucleoside conformations have at least one point where the distance between equivalent atoms exceeds 0.7A. The best superpositions are obtained when N1, C5' and C2' are superimposed with N1, C1' and C4' of 2',3'-didehydro-2',3'-dideoxynucleosides. In all other cases, the (+)-FTC enantiomorph gives a better fit. As an example of the lack of similarity, Fig. 4 shows the superposition of the structures of (-)-FTC, molecule A, and the most closely related 2',3'-dideoxynucleoside, DOC. The fit illustrated was produced by least-squares fitting of the central four atoms: N1', C5', 01' and C4' of (-)-FTC with the corresponding atoms N1, C1', C2', 04' of DOC.Details of this analysis will be published elsewhere (P. Van Roey et al., personal communication) . The observed conformations of (-)-FTC combine conformational features observed in two distinct classes of active anti-HIV-1 nucleosides. But the conformations and the overall shapes of the two molecules of (-)-FTC do not agree sufficiently with those of standard 2',3'-dideoxyribose nucleoside reverse transcriptase inhibitors to allow Crystal structure of (-)-FTC 373 identification of a common 'active site' conformation. This is consistent with the available data regarding the biological activity and metabolism of these compounds. Variants of HIV-1 reversetranscriptase that are resistantto (-)-FTC are not resistant to DOC and AZT . This resistance results from a single amino acid substitution (Met18~Val). This suggests that the 5'"triphosphates of (-)-FTC and DOC do not share common active site geometries.
Materials and Experimental procedures
Compounds. The 3' -thia-2' ,3'-dideoxycytidine nucleosides were synthesized in our laboratories as described previously (Choi et al., 1991) . The detailed synthesis of the (-)-enantiomer of FTC has been reported recently (Hoong et al., 1993) . The optical rotation [ex]D for (-)-FTC, as determined in absolute ethanol (c == 0.88) on a Perkin-Elmer 241MC polarimeter was -120.5".
Crystallography. (-)-FTC (C8H1oFN303S, MW == 247.25) was recrystallized by slow evaporation of an anhydrous acetonitrile solution at 37"C. A crystal with approximate dimensions of 0.3 x 0.1 x 0.05mm was usedforthe intensity data measurements. The crystals belong to the monoclinic space group P2 1, with cell dimensions a = 5.141(1)A, b = 26.451(2)A, c = 7.570(1)A, b = 99.31(1)°, V = 1015.8(2)A3, Z = 4, Peale = 1.61 g crrr ". The intensity data were measured on an Enraf-Nonius CAD4 diffractomer, using Ni-filtered CuKex radiation (A = 1.5418A). The intensity data in the range of 2 < e< 75°were measured in three shells. All data with -33 < k < 33 were measured to allow determination of the absolute configuration. Lorentz (L) and polarization (p) corrections were applied but absorption correction was not considered necessary (fL = 2.91 mm"'). In total 5095 intensity data were measured, yielding 4189 unique data in the + k hemisphere with a merging residual of R = 0.038.3847 reflections had F > 3a(F) and were considered observed. The standard deviation a(F) was calculated according to the method of Stout and Jensen (1989) : a 2(F) = (kI4Lpl)[a 2(1)+(0.0321)2j (F, structure factor, k scale factor, I intensity). The intensities of five reflections were measured every 3 h of the data collection to monitor crystal decay, but did not vary significantly. The structure was determined-by direct methods, using the program MULTAN (Germain et el., 1971) , and refined by full-matrix least-squares. Both enantiomorphs were refined in parallel from the initial model through the end of the anisotropic refinement of the nonhydrogen atoms against the full hemisphere of data. Only the correct enantiomer was refined to completion. All hydrogen atoms except those of the 07'-hydroxyl groups were found in difference maps and included in the refinement after the anisotropic refinement of the non-hydrogen atoms had converged. The maximum value of the shift/e.s.d. during the final cycle was 0.011.
The final crystallographic residuals are R = 0.065, R = 0.077 for the observed data and R = 0.071 for all unique data. The standard deviation of an observation of unit weight was s = 2.047. The final difference map had maximum and minimum densities of -0.62 and 0.59 e.A-3. Atomic scattering parameters were taken from the International Tables of X-ray Crystallography (1974) . Other programs used include Blessing's data reduction program package (1987) and the plotting programs ORTEPII (Johnson, 1976) and PLUTON (Spek, 1992) .
